Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WTAP participates in the DNA damage response via an m6A-FOXM1-dependent manner in hepatocellular carcinoma. | Cell Death Discov | 2025 | 40846737 | PubTator, text mining | PubMed |
| Advancements in non-invasive biomarkers for detection and monitoring of breast cancer recurrence. | Sci Prog | 2025 | 40831186 | PubTator, text mining | PubMed |
| The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers. | Biomark Res | 2025 | 40830526 | PubTator, text mining | PubMed |
| Multigene germline and somatic testing for epithelial ovarian cancer in China. | NPJ Precis Oncol | 2025 | 40804290 | PubTator, text mining | PubMed |
| The Influence of CG sites on dynamic DNA sequence mutagenesis in the genomic evolution of mammalian lifespan. | Nucleic Acids Res | 2025 | 40795962 | PubTator, text mining | PubMed |
| Development and validation of G2M signature-based prognostic model for stratifying colon cancer prognosis. | Discov Oncol | 2025 | 40783878 | PubTator, text mining | PubMed |
| Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort. | J Med Genet | 2025 | 40780707 | PubTator, text mining | PubMed |
| Case Report: Clinical impact of BRCA1 and BRIP1 vs. BRCA1 and BRCA2 germline double heterozygosity in ovarian cancer: a comparative case study. | Front Oncol | 2025 | 40777133 | PubTator, text mining | PubMed |
| Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects. | Food Sci Nutr | 2025 | 40761498 | PubTator, text mining | PubMed |
| Comprehensive review on Fanconi anemia: insights into DNA interstrand cross-links, repair pathways, and associated tumors. | Orphanet J Rare Dis | 2025 | 40739565 | PubTator, text mining | PubMed |
| Participants in Transcription-Replication Conflict and Their Role in Formation and Resolution of R-Loops. | Int J Mol Sci | 2025 | 40725198 | PubTator, text mining | PubMed |
| Predictive value of homologous recombination-related gene mutations in survival outcomes of first-line nivolumab plus chemotherapy for gastric cancer. | Gastric Cancer | 2025 | 40719786 | PubTator, text mining | PubMed |
| NSUN5 Mediates Resistance to Doxorubicin via Up-regulation of DNA Damage Repair Proteins BRCA2 and BRIP1 in Colorectal Cancer. | Am J Pathol | 2025 | 40713976 | PubTator, text mining | PubMed |
| LARS2 DNA methylation predicts the prognosis in colon cancer. | Sci Rep | 2025 | 40691474 | PubTator, text mining | PubMed |
| Untargeted CUT&Tag reads are enriched at accessible chromatin and restrict identification of potential G4-forming sequences in G4-targeted CUT&Tag experiments. | Nucleic Acids Res | 2025 | 40682824 | PubTator, text mining | PubMed |
| Expanding the Genomic Landscape of HBOC and Cancer Risk Among Mutation Carriers. | Int J Mol Sci | 2025 | 40649708 | PubTator, text mining | PubMed |
| Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North India. | JCO Glob Oncol | 2025 | 40644643 | PubTator, text mining | PubMed |
| LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes. | JCO Precis Oncol | 2025 | 40632975 | PubTator, text mining | PubMed |
| Homologous recombination deficiency among patients with germline or somatic non-BRCA1/2 homologous recombination repair gene variations. | NPJ Precis Oncol | 2025 | 40527918 | PubTator, text mining | PubMed |
| Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations. | Ann Oncol | 2025 | 40523834 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=7